Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovascularization in a Rat Model-Reference-Cited by-同舟云学术

Intravitreal Tanibirumab, a Fully Human Monoclonal Antibody Against Vascular Endothelial Growth Factor Receptor 2, Partially Suppresses and Regresses Laser-Induced Choroidal Neovascularization in a Rat Model

Published:2014-12 Issue:10 Volume:30 Page:847-853
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Kim Jaeryung¹,Kim Tae Eun²,Kim Ju-A²,Yun Ji-Hyun²,Sohn Seongsoo³,Shim Sang Ryeol⁴,Lee Sang Hoon⁵,Kim Sang Jin²³

Affiliation:

1. The Laboratory of Vascular Biology and Stem Cells, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.

2. Samsung Biomedical Research Institute, Seoul, Republic of Korea.

3. Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

4. PharmAbcine, Inc., Daejeon, Republic of Korea.

5. Biologics Business, Research & Development Center, Hanwha Chemical, Daejeon, Republic of Korea.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2014.0021

Reference32 articles.

1. Age-related macular degeneration